In ovarian cancer, folate receptor α (FOLR1),21 trophoblast cell surface antigen 2 (TROP2),22,23,24,25 and tissue factor (TF)26,27 are frequently overexpressed and play key roles in tumor progression, making them attractive targets for therapy. This evidence concerns the gene FOLR1 and ovarian cancer.